Application of arctiin in preparation of antidepressant drug, and antidepressant drug

An antidepressant and arctiin technology, applied in the field of medicine, can solve the problems of high price, significant antidepressant effect, and large side effects of antidepressant drugs, and achieve the effect of reducing costs and prices

Inactive Publication Date: 2018-08-17
YANBIAN UNIV
View PDF3 Cites 1 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0006] In order to solve the problem of large side effects and high price of antidepressant drugs in the prior art, the present invention provides an application of

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Application of arctiin in preparation of antidepressant drug, and antidepressant drug
  • Application of arctiin in preparation of antidepressant drug, and antidepressant drug
  • Application of arctiin in preparation of antidepressant drug, and antidepressant drug

Examples

Experimental program
Comparison scheme
Effect test

Example Embodiment

[0038] Example 1 Study on the effect of arctiside and arctigenin on chronic unpredictable depression in mice

[0039] 1. Materials and Reagents

[0040] 1.1 Experimental animals

[0041] 60 SPF grade C57BL / 6 mice, male, body weight (20±2) g, (purchased from Liaoning Changsheng Biotechnology Co., Ltd., license number: SCXK Liao 2015-001).

[0042] 1.2 Experimental drugs

[0043] Arctigoside (Nanjing Chunqiu Bioengineering Co., Ltd., batch number: 20362-31-6, determined by HPLC, purity ≥98%);

[0044] Arctium aglycone (Nanjing Chunqiu Biological Engineering Co., Ltd., batch number: 7770-78-7, determined by HPLC method, purity ≥98%);

[0045] Positive control drug: Sertraline Hydrochloride Tablets (Zhejiang Jingxin Pharmaceutical Co., Ltd., 50mg / tablet, batch number: A1602262);

[0046] 5-HT (serotonin), DA (dopamine), TNF-α (tumor necrosis factor-α), IL-1β (interleukin-1β) kit (Shanghai Enzyme Link Biotechnology Co., Ltd.);

[0047] NO (nitric oxide) kit (Japan Wako Pure Ch...

Example Embodiment

[0096] Example 2 Cytotoxicity test

[0097] Raw264.7 cells in logarithmic growth phase at 2.5.×10 4 The density of cells / well was evenly planted in a sterile 96-well plate, overnight (12h), when the cells grew to 60%, the cells were treated with different concentrations of arctiin and arctigenin, and the cells were treated in an incubator (37°C, 5% CO). 2 ) for 36h, add 10μL of MTT solution (5mg / mL) to each well, incubate for 3.5h, aspirate the medium, add 150μL of dimethyl sulfoxide (DMSO) to each well, and shake for 5min. Absorbance was measured with a microplate reader at a wavelength of 570 nm. Calculate the half-inhibitory concentration (IC) of arctiin and its aglycones 50 ).

[0098] Table 5. IC of arctiin and aglycone on Raw264.7 cells 50 Impact

[0099]

[0100] It can be seen from the data in Table 5 that the 50% inhibitory concentration of arctiside on mice is significantly higher than that of arctigenin, which indicates that arctiside is less toxic than arct...

Example Embodiment

[0101] The preparation of embodiment 3 arctiside sublingual tablet

[0102] Raw materials and their dosage: 5 g of burdock glycosides, 30 g of mannitol, 40 g of lactose, 2 g of sodium carboxymethyl cellulose and 1 g of magnesium stearate.

[0103] Preparation process: drying, crushing and sieving through a 100-mesh sieve for pretreatment, mixing burdockside with mannitol, lactose and sodium carboxymethyl cellulose, adding an appropriate amount of 70% ethanol to make a soft material, and passing through a 14-mesh sieve to make a soft material. Form into granules, blow dry at 55°C for 2 hours, turn once every 0.5h, use 16-mesh and 100-mesh sieves to granulate, add magnesium stearate and mix well, and press the mixture into tablets in a tablet machine, that is, Arctium sublingual tablets were obtained.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention relates to the field of medicines, and provides an application of arctiin in preparation of an antidepressant drug. As an effective component, the arctiin monomer can achieve effective antidepressant effect. The arctiin can also be used in combination with other antidepressant drugs. The invention also provides the antidepressant drug including arctiin and medicinal excipients. Researches show that the toxicity of the arctiin is far less than that of arctigenin. Moreover, pharmacological experiments show that the arctiin and the arctigenin both have significant antidepressant effects, and moreover, the arctiin and the arctigenin have no significant difference in the antidepressant effect at the same dose. Therefore, the antidepressant drug prepared with the arctiin as the effective component has lower toxicity and remarkable antidepressant effect. Meanwhile, the price of raw material of the arctiin is significantly lower than that of arctigenin, and the cost and price ofthe antidepressant drug can be effectively reduced. Therefore, the antidepressant drug with low toxicity, low cost and significant effect is obtained.

Description

technical field [0001] The invention relates to the field of medicines, in particular to an application of arctiin in preparing antidepressant medicines and an antidepressant medicine containing arctiin. Background technique [0002] Depression is a common chronic mental disorder, characterized by persistent depression, often accompanied by anxiety, physical discomfort and sleep disturbance (Xu P, Wang KZ, Lu C, et a1.Antidepressant-like effects and cognitive enhancement of the total phenols extract of Hemerocallis citrina Baroni in chronic unpredictable mild stress rats and its related mechanism[J].Journal of Ethnopharmacology,2016,194:819-826), at least 10% of depressed patients will develop bipolar disorder Phenomena, manifested as manic episode behavior, some patients showed obvious motor agitation and anxiety behavior, and severe patients even had psychotic symptoms such as hallucinations (Yue Lili, Bai Guangze. Research status of depression and anxiety disorders[J] . ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): A61K31/7048A61P25/24
CPCA61K31/7048A61P25/24
Inventor 朴莲荀徐翔陆莹姜彤郭建鹏金学军南极星
Owner YANBIAN UNIV
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products